Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Not yet recruiting × Colonic Neoplasms × Biopsy × Clear all

Status

Completed 6 Recruiting 4 Terminated 3 Withdrawn 2 Unknown 2 Active not recruiting 2

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Lymphoma, T-Cell 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Thrombocytosis 1 Stomach Neoplasms 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms, Nerve Tissue 1 Neoplasms by Histologic Type 1

Interventions

Oxaliplatin 6 tislelizumab 3 Irinotecan 3 Fluorouracil 3 Chemotherapy, Adjuvant 3 sintilimab 2 raltitrexed 2 pembrolizumab 2 cemiplimab 2 Surgical Procedures, Operative 2 Neoadjuvant Therapy 2 Laparoscopy 2 HMPL-013 2 Capecitabine 2 spartalizumab 1 rimegepant sulfate 1 encorafenib 1 XELOX 1 Surgical Fixation Devices 1 Radiofrequency Ablation 1 Preoperative Exercise 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mortality 1 Leucovorin 1 Immune Checkpoint Inhibitors 1 HLX07 1 Genetic Testing 1 Everolimus 1 Electrocardiography 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡